US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Royalty Pharma plc

31.11

-0.6800-2.14%

Post-market: 31.00-0.1100-0.35%19:43 EDT

Volume:7.27M

Turnover:224.94M

Market Cap:13.47B

PE:16.27

High:31.70

Open:31.30

Low:30.45

Close:31.79

Loading ...

Overview Company News Filings

Royalty Pharma plc (NASDAQ:RPRX) is favoured by institutional owners who hold 72% of the company

Simply Wall St.

Jim Cramer Calls Royalty Pharma (RPRX) ‘Disappointing’ But Recommends Holding – ‘I Want You To Stick With It’

Royalty Pharma (RPRX) Gets a Buy from TD Cowen

Here's Why Agios Stock Plummeted More Than 20% on Monday

First Solar and 2 More Cheap Stocks to Consider -- Barrons.com

How Royalty Pharma, Open Text And VICI Properties Can Put Cash In Your Pocket

Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood?

Royalty Pharma price target raised to $39 from $38 at BofA

Royalty Pharma Announces Inaugural Prize for Impact in Healthcare

THOMSON REUTERS

Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues

Simply Wall St.

Citi Keeps Their Buy Rating on Royalty Pharma (RPRX)

Geron Secures up to $375 Million in Funding with Royalty Pharma, Pharmakon Advisors

MT Newswires Live

Geron spikes after Q3 beat and $375M funding deal

BRIEF-Royalty Pharma To Acquire Royalty Interest In Geron’S RYTELO For $125 Mln

Royalty Pharma to Acquire Royalty Interest in Geron’s Rytelo for $125 Million

THOMSON REUTERS

Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million

Stock Track | Royalty Pharma Soars 5% on Strong Q3 Earnings and Strategic Acquisitions

Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions

Royalty Pharma PLC (RPRX): A Strategic SWOT Insight

Royalty Pharma Q3 Net Income, Revenue Climb; Shares Rise Pre-Bell

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RPRX/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RPRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RPRX\",,,,,undefined,":{"symbol":"RPRX","market":"US","secType":"STK","nameCN":"Royalty Pharma plc","latestPrice":31.11,"timestamp":1743796800000,"preClose":31.79,"halted":0,"volume":7265506,"hourTrading":{"tag":"盘后","latestPrice":31,"preClose":31.11,"latestTime":"19:43 EDT","volume":71765,"amount":2231265.4867,"timestamp":1743810230765},"delay":0,"floatShares":388000000,"shares":433000000,"eps":1.911901,"marketStatus":"Market Closed","change":-0.68,"latestTime":"04-04 16:00:00 EDT","open":31.3,"high":31.7,"low":30.45,"amount":224941555.18873,"amplitude":0.039321,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.911901,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1592280000000,"exchange":"NASDAQ","adjPreClose":31.79,"dividendRate":0.027001,"preHourTrading":{"tag":"盘前","latestPrice":31.2,"preClose":31.79,"latestTime":"09:27 EDT","volume":43879,"amount":1393058.469154,"timestamp":1743773260008},"postHourTrading":{"tag":"盘后","latestPrice":31,"preClose":31.11,"latestTime":"19:43 EDT","volume":71765,"amount":2231265.4867,"timestamp":1743810230765},"volumeRatio":1.355562816258694,"impliedVol":0.4634,"impliedVolPercentile":0.9562},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RPRX\",,,,,undefined,":{"symbol":"RPRX","floatShares":388000000,"roa":"4.67%","roe":"13.03%","lyrEps":1.916581,"volumeRatio":1.355562816258694,"shares":433000000,"dividePrice":0.84,"high":31.7,"amplitude":0.039321,"preClose":31.79,"low":30.45,"week52Low":24.05,"pbRate":"1.94","psRate":"5.95","week52High":34.2,"institutionHeld":0.9297,"latestPrice":31.11,"eps":1.911901,"divideRate":0.027001,"volume":7265506,"delay":0,"ttmEps":1.911901,"open":31.3,"prevYearClose":25.51,"prevWeekClose":31.37,"prevMonthClose":31.13,"prevQuarterClose":31.13,"fiveDayClose":31.37,"twentyDayClose":33.01,"sixtyDayClose":26.04},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RPRX\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2493704051","title":"Royalty Pharma plc (NASDAQ:RPRX) is favoured by institutional owners who hold 72% of the company","url":"https://stock-news.laohu8.com/highlight/detail?id=2493704051","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493704051?lang=en_us&edition=fundamental","pubTime":"2024-12-24 18:35","pubTimestamp":1735036522,"startTime":"0","endTime":"0","summary":"Institutions' substantial holdings in Royalty Pharma implies that they have significant influence over the company's share price. A total of 10 investors have a majority stake in the company with 51% ownership. To get a sense of who is truly in control of Royalty Pharma plc , it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 72% to be precise, is institutions. That is, the group stands to benefit the most if the stock rises .Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait.What Does The Institutional Ownership Tell Us About Royalty Pharma?NasdaqGS:RPRX Earnings and Revenue Growth December 24th 2024. We did some more digging and found that 10 of the top shareholders","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/royalty-pharma-plc-nasdaq-rprx-103522908.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","BK4588","TQQQ","NDAQ","USAW.SI","IE00BGHQF748.EUR","LU2095319765.USD","LU2210149790.SGD","QID","QLD","USJW.SI","BK4007","BK4585",".IXIC","MNQmain","RPRX","NQmain","IE00BKPKM429.USD","PSQ","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4112","TSYW.SI","SQQQ"],"gpt_icon":1},{"id":"2493705621","title":"Jim Cramer Calls Royalty Pharma (RPRX) ‘Disappointing’ But Recommends Holding – ‘I Want You To Stick With It’","url":"https://stock-news.laohu8.com/highlight/detail?id=2493705621","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493705621?lang=en_us&edition=fundamental","pubTime":"2024-12-24 17:45","pubTimestamp":1735033516,"startTime":"0","endTime":"0","summary":"We recently published a list of Jim Cramer’s Latest Portfolio Heading Into 2025: Top 10 Stocks. In this article, we are going to take a look at where Royalty Pharma plc  stands against other stocks in Jim Cramer’s latest portfolio heading into 2025.Jim Cramer in a latest program reiterated his view that the market is currently oversold and told investors about his methodology of analyzing market selling and buying indicators based on an oscillator.“Once it touches minus 5, you need to hold your nose and start buying, no matter how bad it looks. Minus 5 means we’re oversold and due for a bullish bounce. When the oscillator goes below minus 8, as it did last night, the only thing you can do is buy hand over fist. Under no circumstances should you sell with the oscillator below minus 8 because, at that point, the selling ship has sailed. The odds are against you if you sell into an extremely oversold market.”Cramer then mentioned a few historical data points explaining the returns one cou","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XZvi9_Jzsy7NmUdEvIXgRg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/117a6ec6167a30d9b152e441b74eca5d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XZvi9_Jzsy7NmUdEvIXgRg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/117a6ec6167a30d9b152e441b74eca5d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jim-cramer-calls-royalty-pharma-094516548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","RPRX","NQmain","MNQmain","PSQ","QLD","TQQQ","USAW.SI","NVIW.SI","TSYW.SI","USJW.SI",".IXIC","BK4007","QID"],"gpt_icon":1},{"id":"2493713049","title":"Royalty Pharma (RPRX) Gets a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2493713049","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493713049?lang=en_us&edition=fundamental","pubTime":"2024-12-24 05:15","pubTimestamp":1734988506,"startTime":"0","endTime":"0","summary":"In a report released today, Steve Scala from TD Cowen maintained a Buy rating on Royalty Pharma (RPRX – Research Report). The company’s shares clos...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/royalty-pharma-rprx-gets-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/royalty-pharma-rprx-gets-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","BK4566","BK4127","TD","BK4585","RPRX","COWN","BK4007"],"gpt_icon":0},{"id":"2490704918","title":"Here's Why Agios Stock Plummeted More Than 20% on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2490704918","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490704918?lang=en_us&edition=fundamental","pubTime":"2024-12-10 23:46","pubTimestamp":1733845560,"startTime":"0","endTime":"0","summary":"Shares of Agios Pharmaceuticals AGIO lost 21% yesterday after management revealed that two thalassemia patients who received its sole-marketed drug Pyrukynd  across two late-stage studies reported hepatocellular  injury in the first six months of treatment.This information was disclosed by Agios as part of an oral presentation at the ASH 2024 annual meeting when it presented detailed results from two phase III studies, ENERGIZE-T and ENERGIZE. While the ENERGIZE-T study evaluated Pyrukynd in adult participants with transfusion-dependent  alpha or beta-thalassemia, the ENERGIZE study evaluated the drug in non-transfusion-dependent  thalassemia patients.Alongside the oral presentation, Agios also disclosed that it has submitted regulatory filings in the United States, European Union, Kingdom of Saudi Arabia and United Arab Emirates seeking label expansion for Pyrukynd in both NTD and TD thalassemia patients.The above submissions also identify hepatocellular injury as a potential risk in ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/.WQmSb1MJO1_eLnmBVS1zA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/.WQmSb1MJO1_eLnmBVS1zA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-agios-stock-plummeted-154600986.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4207","BK4139","RPRX","BK4585","BK4196","BK4007","CSTL","BK4566","TD","AGIO","CTMX"],"gpt_icon":0},{"id":"2489494236","title":"First Solar and 2 More Cheap Stocks to Consider -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2489494236","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489494236?lang=en_us&edition=fundamental","pubTime":"2024-12-06 03:40","pubTimestamp":1733427600,"startTime":"0","endTime":"0","summary":"In the age of soaring stocks and expensive valuations, some investors may turn to the cheapest ones to find bargains. There's a way to do that -- and a few stocks stand out.Large U.S. technology companies have seen their stocks soar over the past couple of years, sending the S&P 500 up 28% this year. The index now trades at its highest valuation level since 2020, at about 22.5 times expected earnings for the coming 12 months. It's too frothy for some investors to keep buying megacap stocks, and it has made smaller, cheaper names look particularly appealing.Lastly, Royalty Pharma is a $15.4 billion pharmaceutical finance company with $6.7 billion of net debt. Analysts expect revenue to jump about 13% next year after having dropped this year. The stock is about flat since mid November, 2023, when its multiple first dropped below 10 times.Give these stocks a look. They're the ones that ma","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2322448957.HKD","LU1548497426.USD","LU0312595415.SGD","LU2023250504.SGD","BK4588","BK4007","BK4596","LU2106854487.HKD","IE00B3CCJ633.GBP","BK4545","LU2322448791.USD","LU0154245756.USD","LU1974910355.USD","LU1978683503.SGD","LU1720051108.HKD","LU2272731600.USD","LU2357125470.USD","FSLR","LU1992135472.HKD","BK4519","LU0823421333.USD","LU0154245673.USD","BK4093","BK4585","LU2473716301.USD","LU0385154629.USD","LU2294711713.HKD","BK4141","LU0124384867.USD","LU2357305700.SGD","IE00BGHQF417.EUR","LU1983299162.USD","LU2048586759.USD","IE00B2PGVK34.USD","LU2211815571.USD","LU0823414478.USD","LU0823414551.USD","LU1720051017.SGD","LU1992135399.USD","LU2272731865.HKD","RPRX","LU0823421416.USD","LU1917777945.USD","LU0823434583.USD","LU2249611893.SGD","LU0823434740.USD","LU0471298777.SGD","FMC","LU0323239441.USD","LU2272731782.SGD"],"gpt_icon":0},{"id":"2487552259","title":"How Royalty Pharma, Open Text And VICI Properties Can Put Cash In Your Pocket","url":"https://stock-news.laohu8.com/highlight/detail?id=2487552259","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487552259?lang=en_us&edition=fundamental","pubTime":"2024-11-29 21:00","pubTimestamp":1732885215,"startTime":"0","endTime":"0","summary":"Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. Royalty Pharma, Open Text and VICI Properties have rewarded shareholders for decades and recently announced dividend increases. These companies currently offer dividend yields of around 3-5%.The company has consistently increased its dividends since 2020. According to the company's most recent dividend hike announcement on Jan. 19, its board of directors raised the quarterly dividend by 5% to $0.21 per share or $0.84 annualized. The dividend yield on the stock currently stands at 3.20%.Open Text has increased its dividend every year since 2014. According to its most recent dividend announcement on Aug. 1, it raised the quarterly dividend by 5% to $0.2625 per share, equal to $1.05 annualized. The dividend yield on the stock is 3.50%.VICI Properties has consistently ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dvv.hjDtSE453KshS4wNOQ--~B/aD00ODA7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/2478d504468c1442136cdc23a48f5c5d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dvv.hjDtSE453KshS4wNOQ--~B/aD00ODA7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/2478d504468c1442136cdc23a48f5c5d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/royalty-pharma-open-text-vici-130015790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4561","BK4585","BK4007","OTEX","BK4588","BK4234","RPRX","BK4084","BK4023","VICI"],"gpt_icon":0},{"id":"2486564874","title":"Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood?","url":"https://stock-news.laohu8.com/highlight/detail?id=2486564874","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486564874?lang=en_us&edition=fundamental","pubTime":"2024-11-28 00:11","pubTimestamp":1732723908,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Cheapest Stocks to Buy On Robinhood. In this article, we are going to take a look at where Royalty Pharma  stands against other cheapest stocks to buy on Robinhood.While the market has been on an upward trajectory for nearly two years now, the combination of seasonal trends, strong retail, and corporate activity, and positive market momentum following the November election still suggests a potential for continued growth in U.S. equities.Goldman Sachs’ Scott Rubner predicts a year-end rally that will push the S&P to 6,200 points as reported by Bloomberg on November 25. He attributes this potential rally to growing retail enthusiasm in equities and crypto, seasonal trading patterns, and increasing corporate buyback demand.Rubner noted that the recent consolidation phase is typical, and highlighted significant inflows into U.S. equities, with the broader market gaining over 3% since the November 5 presidential vote and the Russell 2000 rising 6.5%. Histo","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XZvi9_Jzsy7NmUdEvIXgRg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/117a6ec6167a30d9b152e441b74eca5d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XZvi9_Jzsy7NmUdEvIXgRg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/117a6ec6167a30d9b152e441b74eca5d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-royalty-pharma-rprx-cheapest-161148049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HOOD","NQmain","BK4547","RPRX","MNQmain","BK4539","PSQ","LU1861558580.USD","LU1861559042.SGD","QLD","TQQQ","SQQQ","QID","BK4007",".IXIC","BK4127"],"gpt_icon":1},{"id":"2484947648","title":"Royalty Pharma price target raised to $39 from $38 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2484947648","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484947648?lang=en_us&edition=fundamental","pubTime":"2024-11-19 22:05","pubTimestamp":1732025112,"startTime":"0","endTime":"0","summary":"BofA analyst Charlie Yang raised the firm’s price target on Royalty Pharma (RPRX) to $39 from $38 and keeps a Buy rating on the shares. The firm is...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/royalty-pharma-price-target-raised-to-39-from-38-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/royalty-pharma-price-target-raised-to-39-from-38-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2483358310","title":"Royalty Pharma Announces Inaugural Prize for Impact in Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2483358310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483358310?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:30","pubTimestamp":1731619801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUA4YJ4NK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2483100136","title":"Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2483100136","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483100136?lang=en_us&edition=fundamental","pubTime":"2024-11-13 19:59","pubTimestamp":1731499169,"startTime":"0","endTime":"0","summary":"The market shrugged off Royalty Pharma plc's  solid earnings report. We think that investors might be worried about some concerning underlying factors.NasdaqGS:RPRX Earnings and Revenue History November 13th 2024. For anyone who wants to understand Royalty Pharma's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from US$349m worth of unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. If Royalty Pharma doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click her","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/royalty-pharmas-nasdaq-rprx-profits-115929067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2095319765.USD","LU2210149790.SGD","BK4007","NQmain","NDAQ","PSQ","IE00B3QW5Z07.USD","BK4112","IE00BKPKM429.USD","SQQQ","MNQmain","QID","IE00B64PRP62.GBP","BK4585","LU2210150020.SGD","QLD","RPRX","IE00BGHQF748.EUR","TQQQ",".IXIC","BK4588"],"gpt_icon":1},{"id":"2482441481","title":"Citi Keeps Their Buy Rating on Royalty Pharma (RPRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482441481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482441481?lang=en_us&edition=fundamental","pubTime":"2024-11-09 19:25","pubTimestamp":1731151514,"startTime":"0","endTime":"0","summary":"In a report released on November 7, Geoff Meacham from Citi maintained a Buy rating on Royalty Pharma (RPRX – Research Report). The company’s share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-keeps-their-buy-rating-on-royalty-pharma-rprx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-keeps-their-buy-rating-on-royalty-pharma-rprx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RPRX"],"gpt_icon":0},{"id":"2481132706","title":"Geron Secures up to $375 Million in Funding with Royalty Pharma, Pharmakon Advisors","url":"https://stock-news.laohu8.com/highlight/detail?id=2481132706","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481132706?lang=en_us&edition=fundamental","pubTime":"2024-11-08 00:42","pubTimestamp":1730997734,"startTime":"0","endTime":"0","summary":"Geron  said Thursday it secured up to $375 million in synthetic royalty and debt financings with Royalty Pharma  and investment funds managed by Pharmakon Advisors.The company said $250 million in cash was provided at closing, with another $125 million in debt available.Royalty Pharma has provided $125 million at closing and will receive tiered royalty payments on US net sales of Geron's Rytelo treatment of low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia.Geron said investment funds managed by Pharmakon have committed to a five-year senior secured term loan of up to $250 million, with a first tranche of $125 million drawn at closing.The company used part of the proceeds to fully repay amounts owned under its existing loan with Hercules Capital and Silicon Valley Bank.Geron can draw a second tranche of $75 million and a third tranche of $50 million, if requested, before Dec. 31, 2025, the company said.Price: 4.29, Change: +0.02, Percent Change: +0.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4007","GERN","RPRX"],"gpt_icon":0},{"id":"2481090235","title":"Geron spikes after Q3 beat and $375M funding deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2481090235","media":"seekingalpha","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481090235?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:34","pubTimestamp":1730982855,"startTime":"0","endTime":"0","summary":"mohd izzuanGeron  shares traded higher in the premarket on Thursday after the company reported better-than-expected earnings for Q3 and announced a $375M funding deal with Royalty Pharma  and investment manager Pharmakon Advisors. Foster City, California-based biotech’s Q3 beat was driven by its newly launched blood disorder therapy Rytelo, which added $28.2M to the topline during its first full quarter of U.S. launch. “The initial full quarter of product revenue from our U.S. launch exceeded our expectations and demonstrates strong execution as a commercial company,” said CEO John Scarlett. Meanwhile, GERN’s net loss narrowed ~41% YoY to $26.4M as the company cut its R&D expenses by ~31% YoY to $20.2M. As for guidance, Geron  lowered its full-year outlook for total operating expenses to $ 260M-$270M from $270M-$280M projected three months ago. As part of the funding agreement, GERN said Royalty Pharma  is expected to provide the company with $125M in cash upfront in exchange for a syn","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2155546196/image_2155546196.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2155546196/image_2155546196.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4260409-geron-stock-spikes-q-3-beat-funding-deal","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["QID",".IXIC","MNQmain","GERN","TQQQ","NQmain","PSQ","SQQQ","BK4007","QLD","RPRX","BK4139"],"gpt_icon":1},{"id":"2481903980","title":"BRIEF-Royalty Pharma To Acquire Royalty Interest In Geron’S RYTELO For $125 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2481903980","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481903980?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:13","pubTimestamp":1730981617,"startTime":"0","endTime":"0","summary":"BRIEF-Royalty Pharma To Acquire Royalty Interest In Geron’S RYTELO For $125 MlnNov 7 (Reuters) - Geron Corp GERN.O:ROYALTY PHARMA TO ACQUIRE ROYALTY INTEREST IN GERON’S RYTELO FOR $125 MILLIONROYALTY ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA9W2ZQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RPRX","BK4139","GERN"],"gpt_icon":0},{"id":"2481790357","title":"Royalty Pharma to Acquire Royalty Interest in Geron’s Rytelo for $125 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2481790357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481790357?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:10","pubTimestamp":1730981400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA9W2ZQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GERN","BK4139","RPRX"],"gpt_icon":0},{"id":"2481202903","title":"Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2481202903","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481202903?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:10","pubTimestamp":1730981400,"startTime":"0","endTime":"0","summary":"RYTELO  is FDA approved for the treatment of low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. Transaction increases Royalty Pharma’s synthetic royalty funding to $925 million in 2024, highlighting the significant opportunity for this attractive funding modality. NEW YORK, Nov. 07, 2024  -- Royalty Pharma plc  today announced that it will acquire a synthetic royalty on U.S. sales of Geron Corporation’s  RYTELO for $125 million in cash upfront.“RYTELO is an important therapy for the lower-risk MDS patient population, who otherwise have limited treatment options, and we look forward to its development in other hematologic malignancy indications. We are delighted to establish this partnership with Geron to help fuel their execution of significant commercial and development opportunities ahead” said Pablo Legorreta, founder and Chief Executive Officer of Royalty Pharma.Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/O1LzmG.aXISIKwBYMnszhQ--~B/aD0yMTt3PTM0MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/d4dc9c9f0a11200f9e82d2cebec20597","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/O1LzmG.aXISIKwBYMnszhQ--~B/aD0yMTt3PTM0MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/d4dc9c9f0a11200f9e82d2cebec20597"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/royalty-pharma-acquire-royalty-interest-121000169.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU0868494617.USD","IE000M9KFDE8.USD","LU0225771236.USD","LU1023059063.AUD","SG9999001176.USD","LU0306806265.USD","BK4568","BK4585","GERN","BK4550","LU0170899867.USD","LU0289739699.SGD","SG9999002232.USD","IE0002270589.USD","LU1894683348.USD","BK4007","SG9999002224.SGD","LU1883839398.USD","IE00BLSP4452.SGD","IE00B19Z3581.USD","LU0456855351.SGD","SG9999003800.SGD","LU1057294990.SGD","TD","LU1066051498.USD","BK4139","SGXZ57979304.SGD","BK4592","BK4207","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0225284248.USD","LU0321505439.SGD","LU0234572021.USD","LU1066053197.SGD","LU1894683264.USD","RPRX","SG9999001176.SGD","BK4566","BK4533","LU0321505868.SGD","LU0306807586.USD","LU0985481810.HKD","SG9999011175.SGD","IE00BLSP4239.USD","SG9999013999.USD","BK4581","BK4534"],"gpt_icon":1},{"id":"1139440275","title":"Stock Track | Royalty Pharma Soars 5% on Strong Q3 Earnings and Strategic Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=1139440275","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139440275?lang=en_us&edition=fundamental","pubTime":"2024-11-07 16:28","pubTimestamp":1730968139,"startTime":"0","endTime":"0","summary":"Royalty Pharma plc , a leading acquirer of biopharmaceutical royalties, witnessed a remarkable 5.11% surge in its stock price on November 7, 2024. This surge came on the heels of the company's impressive third-quarter earnings report, released on November 6, 2024.In the third quarter, Royalty Pharma reported a 15% growth in both portfolio receipts and royalty receipts, showcasing its robust financial performance. Furthermore, the company raised its full-year 2024 guidance, expecting portfolio re","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Royalty Pharma Soars 5% on Strong Q3 Earnings and Strategic Acquisitions","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["RPRX"],"gpt_icon":0},{"id":"2481473559","title":"Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2481473559","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481473559?lang=en_us&edition=fundamental","pubTime":"2024-11-07 15:10","pubTimestamp":1730963457,"startTime":"0","endTime":"0","summary":"Portfolio Receipts Growth: 15% growth in the third quarter.Royalty Receipts Growth: 15% growth in the third quarter, bringing year-to-date growth to 14%.Share Repurchase: $95 million repurchased in the third quarter, totaling $180 million for the first nine months of 2024.Full Year 2024 Guidance: Portfolio receipts expected between $2.75 billion and $2.8 billion.Expected Royalty Receipts Growth: 11% to 13% for the full year 2024.Operating Professional Costs: 7.5% of portfolio receipts in the third quarter.Net Interest Paid: $62 million in the third quarter.Portfolio Cash Flow: $617 million in the third quarter, with a margin of around 84%.Cash and Equivalents: $950 million at the end of the third quarter.Investment-Grade Debt: $7.8 billion outstanding with a weighted average cost of 3.1%.Leverage Ratio: Approximately 3 times total debt to adjusted EBITDA.Raised Full Year 2024 Guidance: Portfolio receipts expected to be in the range of $2.75 billion to $2.8 billion.Interest Paid for Ful","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/royalty-pharma-plc-rprx-q3-071057478.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RPRX"],"gpt_icon":0},{"id":"2481910637","title":"Royalty Pharma PLC (RPRX): A Strategic SWOT Insight","url":"https://stock-news.laohu8.com/highlight/detail?id=2481910637","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481910637?lang=en_us&edition=fundamental","pubTime":"2024-11-07 13:08","pubTimestamp":1730956125,"startTime":"0","endTime":"0","summary":"Robust royalty revenue streams from a diverse portfolio of biopharmaceutical products.Strategic investments in development-stage candidates with potential for high returns.Market competition and regulatory changes pose significant threats.Proactive share repurchase program reflects confidence in long-term value.On November 6, 2024, Royalty Pharma PLC , the industry-leading acquirer of biopharmaceutical royalties, filed its 10-Q report, revealing the latest financials and strategic insights. With a portfolio that includes royalties on over 35 commercial products and 10 development-stage candidates, RPRX stands out for its unique business model. The financial tables from the filing indicate a solid balance sheet, with dividends to Class A shareholders increasing to $282.8 million in the first nine months of 2024, up from $269.0 million in the same period of 2023. Additionally, RPRX's share repurchase program, with $179.7 million spent on buybacks in the first nine months of 2024, signals","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/a381Yd6Y4WzO3t2Wzm8AbQ--~B/aD03ODQ7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/ac434984bebb4e40ebef3a35f19ae4d0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/a381Yd6Y4WzO3t2Wzm8AbQ--~B/aD03ODQ7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/ac434984bebb4e40ebef3a35f19ae4d0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/royalty-pharma-plc-rprx-strategic-050845613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","INAQU","RPRX"],"gpt_icon":0},{"id":"2481934409","title":"Royalty Pharma Q3 Net Income, Revenue Climb; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2481934409","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481934409?lang=en_us&edition=fundamental","pubTime":"2024-11-06 21:08","pubTimestamp":1730898507,"startTime":"0","endTime":"0","summary":"Royalty Pharma (RPRX) reported Q3 net income Wednesday of $544 million, up from $72 million a year earlier.Comparable analysts' estimates were not available.Total income and other revenue for the quar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RPRX"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":102}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RPRX\",params:#limit:5,,,undefined,":[{"date":"2025-02-21","symbol":"RPRX","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-21","defaultRemindTime":1740148200000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-10","payableDate":"2025-02-21","currency":"USD","dateTimestamp":1740114000000,"payDate":"2025-03-10"},{"market":"US","date":"2025-02-11","symbol":"RPRX","fiscalQuarterEnding":"2024/12","expectedEps":1.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"pre","actualEps":1.15},{"date":"2025-01-10","symbol":"RPRX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1736499600000,"name":null,"time":"Pre-Market","dateTimestamp":1736485200000,"actualEps":null},{"date":"2024-11-15","symbol":"RPRX","amount":0.21,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-15","defaultRemindTime":1731681000000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-10","payableDate":"2024-11-15","currency":"USD","dateTimestamp":1731646800000,"payDate":"2024-12-10"},{"market":"US","date":"2024-11-06","symbol":"RPRX","fiscalQuarterEnding":"2024/09","expectedEps":0.95,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":1.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RPRX\",market:\"US\",,,undefined,":[{"executeDate":"2020-09-14","recordDate":"2020-09-15","paymentDate":"2020-09-30","value":0.15,"currency":"USD"},{"executeDate":"2020-11-19","recordDate":"2020-11-20","paymentDate":"2020-12-15","value":0.15,"currency":"USD"},{"executeDate":"2021-02-18","recordDate":"2021-02-19","paymentDate":"2021-03-15","value":0.17,"currency":"USD"},{"executeDate":"2021-05-19","recordDate":"2021-05-20","paymentDate":"2021-06-15","value":0.17,"currency":"USD"},{"executeDate":"2021-08-19","recordDate":"2021-08-20","paymentDate":"2021-09-15","value":0.17,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RPRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.4286,"hold":0.2857,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":7,"updateTime":1737777600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RPRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RPRX","date":"2025-04-04","current":16.03687,"percent":0.289831,"low":4.782628,"twenty":13.112851,"median":27.609843,"eighty":56.720287,"high":536.452748,"avg":55.378503,"sd":103.377592,"marketCap":13775398729},"quantilePoints":[{"date":"2020-06-19","current":14.493143,"twenty":11.284116,"median":14.101803,"eighty":14.605539,"marketCap":29744726270},{"date":"2020-06-26","current":14.667652,"twenty":13.86334,"median":14.765259,"eighty":15.090024,"marketCap":30102877055},{"date":"2020-07-02","current":13.525947,"twenty":13.657273,"median":14.453213,"eighty":15.061038,"marketCap":27759721067},{"date":"2020-07-10","current":14.090884,"twenty":13.702231,"median":14.303845,"eighty":14.939768,"marketCap":28919158357},{"date":"2020-07-17","current":13.070449,"twenty":12.982993,"median":14.096343,"eighty":14.745738,"marketCap":26824886813},{"date":"2020-07-24","current":12.396074,"twenty":12.739177,"median":13.744823,"eighty":14.562947,"marketCap":25440846489},{"date":"2020-07-31","current":12.733261,"twenty":12.727345,"median":13.546651,"eighty":14.445227,"marketCap":26132866651},{"date":"2020-08-07","current":12.943264,"twenty":12.727345,"median":13.049744,"eighty":14.381339,"marketCap":26563861664},{"date":"2020-08-14","current":11.767963,"twenty":12.672923,"median":13.040871,"eighty":14.326324,"marketCap":27568713430},{"date":"2020-08-21","current":10.87649,"twenty":12.399623,"median":12.943264,"eighty":14.243506,"marketCap":25480266520},{"date":"2020-08-28","current":10.902405,"twenty":11.724426,"median":12.82791,"eighty":14.142394,"marketCap":25540977186},{"date":"2020-09-04","current":10.308954,"twenty":11.155853,"median":12.739177,"eighty":14.095252,"marketCap":24150702934},{"date":"2020-09-11","current":9.992792,"twenty":10.871826,"median":12.733261,"eighty":14.02108,"marketCap":23410032809},{"date":"2020-09-18","current":10.879082,"twenty":10.796154,"median":12.702205,"eighty":13.847754,"marketCap":25486337586},{"date":"2020-09-25","current":10.384107,"twenty":10.708043,"median":12.48185,"eighty":13.702231,"marketCap":24326763866},{"date":"2020-10-02","current":11.006065,"twenty":10.708043,"median":12.399031,"eighty":13.609948,"marketCap":25783819850},{"date":"2020-10-09","current":11.423295,"twenty":10.746397,"median":11.786104,"eighty":13.555525,"marketCap":26761261572},{"date":"2020-10-16","current":10.835026,"twenty":10.793044,"median":11.635798,"eighty":13.536595,"marketCap":25383129454},{"date":"2020-10-23","current":10.109409,"twenty":10.646884,"median":11.555461,"eighty":13.531271,"marketCap":23683230806},{"date":"2020-10-30","current":9.510774,"twenty":10.520937,"median":11.425887,"eighty":13.343748,"marketCap":22280814422},{"date":"2020-11-06","current":10.428162,"twenty":10.426607,"median":11.350733,"eighty":13.062167,"marketCap":24429971998},{"date":"2020-11-13","current":11.839513,"twenty":10.431272,"median":11.298903,"eighty":13.042645,"marketCap":26335125648},{"date":"2020-11-20","current":11.347605,"twenty":10.436973,"median":11.376648,"eighty":13.013067,"marketCap":25240954948},{"date":"2020-11-27","current":11.693346,"twenty":10.440083,"median":11.376648,"eighty":12.976391,"marketCap":26010000640},{"date":"2020-12-04","current":12.078439,"twenty":10.460815,"median":11.427394,"eighty":12.936509,"marketCap":26866579988},{"date":"2020-12-11","current":11.921029,"twenty":10.519382,"median":11.508814,"eighty":12.902046,"marketCap":26516445364},{"date":"2020-12-18","current":12.480398,"twenty":10.521974,"median":11.559348,"eighty":12.85453,"marketCap":27760673760},{"date":"2020-12-24","current":13.745303,"twenty":10.524047,"median":11.635798,"eighty":12.943264,"marketCap":30574255560},{"date":"2020-12-31","current":14.068557,"twenty":10.543742,"median":11.676481,"eighty":13.053885,"marketCap":31293282020},{"date":"2021-01-08","current":14.411487,"twenty":10.555923,"median":11.757997,"eighty":13.527722,"marketCap":32056075308},{"date":"2021-01-15","current":14.602628,"twenty":10.60542,"median":11.812808,"eighty":13.593485,"marketCap":32481238780},{"date":"2021-01-22","current":14.380567,"twenty":10.622005,"median":11.873244,"eighty":13.745015,"marketCap":31987298864},{"date":"2021-01-29","current":13.214043,"twenty":10.657768,"median":11.921029,"eighty":13.791964,"marketCap":29392551204},{"date":"2021-02-05","current":13.222476,"twenty":10.690421,"median":12.020816,"eighty":13.750925,"marketCap":29411308416},{"date":"2021-02-12","current":13.486701,"twenty":10.713226,"median":12.120603,"eighty":13.745015,"marketCap":29999034392},{"date":"2021-02-19","current":30.465593,"twenty":10.746397,"median":12.325799,"eighty":13.808268,"marketCap":29705171404},{"date":"2021-02-26","current":28.996916,"twenty":10.793044,"median":12.399031,"eighty":13.908662,"marketCap":28273153215},{"date":"2021-03-05","current":26.487628,"twenty":10.814813,"median":12.418558,"eighty":14.081953,"marketCap":25826496409},{"date":"2021-03-12","current":29.214845,"twenty":10.822587,"median":12.523287,"eighty":14.16469,"marketCap":28485642020},{"date":"2021-03-19","current":29.1339,"twenty":10.827252,"median":12.685937,"eighty":14.372357,"marketCap":28406717607},{"date":"2021-03-26","current":26.624611,"twenty":10.830362,"median":12.725867,"eighty":14.420638,"marketCap":25960060801},{"date":"2021-04-01","current":26.780274,"twenty":10.841764,"median":12.736219,"eighty":14.558244,"marketCap":26111838518},{"date":"2021-04-09","current":26.344418,"twenty":10.870271,"median":12.777628,"eighty":14.859728,"marketCap":25686860909},{"date":"2021-04-16","current":26.070451,"twenty":10.877008,"median":12.890883,"eighty":15.364506,"marketCap":25419732126},{"date":"2021-04-23","current":27.153866,"twenty":10.880637,"median":12.943264,"eighty":25.867466,"marketCap":26476105040},{"date":"2021-04-30","current":27.609843,"twenty":10.889966,"median":13.040871,"eighty":26.105319,"marketCap":26920701720},{"date":"2021-05-07","current":25.708529,"twenty":10.902405,"median":13.112851,"eighty":26.233724,"marketCap":25066844306},{"date":"2021-05-14","current":25.415982,"twenty":10.923137,"median":13.188745,"eighty":26.203698,"marketCap":24727692206},{"date":"2021-05-21","current":25.397262,"twenty":11.006583,"median":13.242152,"eighty":26.105319,"marketCap":24709478831},{"date":"2021-05-28","current":25.035336,"twenty":11.014357,"median":13.396752,"eighty":26.063326,"marketCap":24357353580},{"date":"2021-06-04","current":28.211553,"twenty":11.037163,"median":13.462808,"eighty":26.226114,"marketCap":27447556215},{"date":"2021-06-11","current":28.01811,"twenty":11.073444,"median":13.525947,"eighty":26.468948,"marketCap":27259351339},{"date":"2021-06-18","current":27.46898,"twenty":11.088992,"median":13.552567,"eighty":26.637064,"marketCap":26725092338},{"date":"2021-06-25","current":26.570403,"twenty":11.125544,"median":13.593515,"eighty":26.668197,"marketCap":25850850335},{"date":"2021-07-02","current":26.35824,"twenty":11.210793,"median":13.670814,"eighty":26.643499,"marketCap":25644432084},{"date":"2021-07-09","current":26.064954,"twenty":11.239817,"median":13.722576,"eighty":26.638351,"marketCap":25359089208},{"date":"2021-07-16","current":26.726929,"twenty":11.289271,"median":13.759358,"eighty":26.648439,"marketCap":26003137199},{"date":"2021-07-23","current":26.581925,"twenty":11.338048,"median":13.881632,"eighty":26.679943,"marketCap":25862059759},{"date":"2021-07-30","current":25.17802,"twenty":11.350107,"median":13.916375,"eighty":26.648439,"marketCap":24496173638},{"date":"2021-08-06","current":24.380496,"twenty":11.371465,"median":14.057313,"eighty":26.638351,"marketCap":23720247719},{"date":"2021-08-13","current":24.202628,"twenty":11.413966,"median":14.101803,"eighty":26.627102,"marketCap":23515781358},{"date":"2021-08-20","current":24.371352,"twenty":11.425707,"median":14.162722,"eighty":26.606281,"marketCap":23679717867},{"date":"2021-08-27","current":24.490085,"twenty":11.428044,"median":14.303845,"eighty":26.590141,"marketCap":23795080595},{"date":"2021-09-03","current":24.565073,"twenty":11.442485,"median":14.393216,"eighty":26.58299,"marketCap":23867941265},{"date":"2021-09-10","current":24.046401,"twenty":11.483683,"median":14.412385,"eighty":26.575012,"marketCap":23363988295},{"date":"2021-09-17","current":24.058899,"twenty":11.513281,"median":14.476137,"eighty":26.520738,"marketCap":23376131740},{"date":"2021-09-24","current":23.18403,"twenty":11.53978,"median":14.588573,"eighty":26.47642,"marketCap":22526090586},{"date":"2021-10-01","current":22.640362,"twenty":11.560125,"median":14.847176,"eighty":26.437867,"marketCap":21997850726},{"date":"2021-10-08","current":22.177931,"twenty":11.592778,"median":15.062517,"eighty":26.384717,"marketCap":21548543258},{"date":"2021-10-15","current":23.99016,"twenty":11.640462,"median":15.413014,"eighty":26.360183,"marketCap":23309342792},{"date":"2021-10-22","current":23.433993,"twenty":11.659417,"median":22.124814,"eighty":26.350751,"marketCap":22768959487},{"date":"2021-10-29","current":24.702553,"twenty":11.679854,"median":22.271667,"eighty":26.344954,"marketCap":24001519161},{"date":"2021-11-05","current":24.696304,"twenty":11.723704,"median":22.559124,"eighty":26.333991,"marketCap":23995447438},{"date":"2021-11-12","current":32.51009,"twenty":11.752375,"median":22.640362,"eighty":26.350751,"marketCap":25452734666},{"date":"2021-11-19","current":32.2309,"twenty":11.763977,"median":22.8872,"eighty":26.47642,"marketCap":25234152021},{"date":"2021-11-26","current":32.486824,"twenty":11.775219,"median":22.924694,"eighty":26.585121,"marketCap":25434519446},{"date":"2021-12-03","current":29.19859,"twenty":11.807468,"median":23.015305,"eighty":26.640925,"marketCap":22860101627},{"date":"2021-12-10","current":29.291653,"twenty":11.847383,"median":23.171532,"eighty":26.80037,"marketCap":22932962508},{"date":"2021-12-17","current":29.888809,"twenty":11.870433,"median":23.215276,"eighty":26.895847,"marketCap":23400486499},{"date":"2021-12-23","current":31.21496,"twenty":11.891419,"median":23.371502,"eighty":27.107873,"marketCap":24438754063},{"date":"2021-12-31","current":30.904749,"twenty":11.910529,"median":23.48711,"eighty":27.173363,"marketCap":24195884457},{"date":"2022-01-07","current":31.222715,"twenty":11.93171,"median":23.58397,"eighty":27.251023,"marketCap":24444825803},{"date":"2022-01-14","current":30.757399,"twenty":11.982869,"median":23.843307,"eighty":27.501351,"marketCap":24080521395},{"date":"2022-01-21","current":30.354125,"twenty":12.0166,"median":23.915171,"eighty":27.798092,"marketCap":23764790907},{"date":"2022-01-28","current":30.602294,"twenty":12.025032,"median":23.99016,"eighty":27.981993,"marketCap":23959086592},{"date":"2022-02-04","current":30.997812,"twenty":12.078439,"median":24.05265,"eighty":28.604645,"marketCap":24268745339},{"date":"2022-02-11","current":30.912504,"twenty":12.120603,"median":24.152635,"eighty":28.953331,"marketCap":24201956198},{"date":"2022-02-18","current":38.611798,"twenty":12.199308,"median":24.193255,"eighty":29.097649,"marketCap":23928812189},{"date":"2022-02-25","current":37.690836,"twenty":12.300501,"median":24.209173,"eighty":29.140126,"marketCap":23358066605},{"date":"2022-03-04","current":37.641849,"twenty":12.370773,"median":24.296364,"eighty":29.218581,"marketCap":23327707798},{"date":"2022-03-11","current":37.494887,"twenty":12.393263,"median":24.333858,"eighty":29.372308,"marketCap":23236631375},{"date":"2022-03-18","current":38.523621,"twenty":12.400806,"median":24.371352,"eighty":29.55223,"marketCap":23874166335},{"date":"2022-03-25","current":37.592862,"twenty":12.401989,"median":24.41822,"eighty":29.826979,"marketCap":23297348990},{"date":"2022-04-01","current":38.56281,"twenty":12.415244,"median":24.490085,"eighty":30.011342,"marketCap":23898453382},{"date":"2022-04-08","current":40.581088,"twenty":12.46803,"median":24.558469,"eighty":30.160243,"marketCap":25149236257},{"date":"2022-04-14","current":43.206807,"twenty":12.481269,"median":24.62444,"eighty":30.337063,"marketCap":26776468347},{"date":"2022-04-22","current":41.977613,"twenty":12.531575,"median":24.702553,"eighty":30.374674,"marketCap":26014702030},{"date":"2022-04-29","current":41.717726,"twenty":12.617931,"median":24.768168,"eighty":30.481311,"marketCap":25853642688},{"date":"2022-05-06","current":40.037043,"twenty":12.672923,"median":24.835282,"eighty":30.64107,"marketCap":24117113377},{"date":"2022-05-13","current":40.258799,"twenty":12.697537,"median":24.934608,"eighty":30.867524,"marketCap":24250692555},{"date":"2022-05-20","current":39.835446,"twenty":12.713191,"median":25.066536,"eighty":30.997812,"marketCap":23995677761},{"date":"2022-05-27","current":41.599415,"twenty":12.727345,"median":25.116457,"eighty":31.059854,"marketCap":25058239402},{"date":"2022-06-03","current":40.843428,"twenty":12.733261,"median":25.194498,"eighty":31.165326,"marketCap":24602855842},{"date":"2022-06-10","current":40.803109,"twenty":12.735627,"median":25.334861,"eighty":31.219613,"marketCap":24578568718},{"date":"2022-06-17","current":39.664089,"twenty":12.739177,"median":25.403502,"eighty":31.585662,"marketCap":23892457487},{"date":"2022-06-24","current":43.54482,"twenty":12.746867,"median":25.497104,"eighty":32.196777,"marketCap":26230093099},{"date":"2022-07-01","current":43.081148,"twenty":12.778811,"median":25.671953,"eighty":32.432537,"marketCap":25950791181},{"date":"2022-07-08","current":43.302904,"twenty":12.783544,"median":25.758729,"eighty":32.51009,"marketCap":26084370359},{"date":"2022-07-15","current":44.280647,"twenty":12.872277,"median":25.81215,"eighty":32.913364,"marketCap":26673333098},{"date":"2022-07-22","current":43.575059,"twenty":12.909488,"median":25.883655,"eighty":37.112786,"marketCap":26248308441},{"date":"2022-07-29","current":43.837135,"twenty":12.927331,"median":25.924329,"eighty":37.494887,"marketCap":26406174742},{"date":"2022-08-05","current":55.302721,"twenty":12.943264,"median":26.008185,"eighty":37.641849,"marketCap":25776487684},{"date":"2022-08-12","current":57.582574,"twenty":12.984673,"median":26.031171,"eighty":37.739824,"marketCap":26839122629},{"date":"2022-08-19","current":57.452297,"twenty":13.031997,"median":26.064954,"eighty":37.955368,"marketCap":26778400632},{"date":"2022-08-26","current":56.084385,"twenty":13.049744,"median":26.130056,"eighty":38.170912,"marketCap":26140819665},{"date":"2022-09-02","current":54.807667,"twenty":13.070449,"median":26.166685,"eighty":38.396254,"marketCap":25545744095},{"date":"2022-09-09","current":56.839993,"twenty":13.104371,"median":26.235626,"eighty":38.531459,"marketCap":26493007247},{"date":"2022-09-16","current":54.651334,"twenty":13.130841,"median":26.335729,"eighty":38.654091,"marketCap":25472877699},{"date":"2022-09-23","current":52.540842,"twenty":13.157825,"median":26.35824,"eighty":38.942952,"marketCap":24489181349},{"date":"2022-09-30","current":52.345426,"twenty":13.203924,"median":26.443047,"eighty":39.5308,"marketCap":24398098354},{"date":"2022-10-07","current":53.231312,"twenty":13.220789,"median":26.570403,"eighty":39.868964,"marketCap":24811007933},{"date":"2022-10-14","current":53.947837,"twenty":13.238217,"median":26.594475,"eighty":40.109618,"marketCap":25144978916},{"date":"2022-10-21","current":53.439755,"twenty":13.287126,"median":26.637064,"eighty":40.381773,"marketCap":24908163128},{"date":"2022-10-28","current":55.706581,"twenty":13.343344,"median":26.697563,"eighty":40.596976,"marketCap":25964725874},{"date":"2022-11-04","current":54.638307,"twenty":13.42205,"median":26.813768,"eighty":40.835364,"marketCap":25466805499},{"date":"2022-11-11","current":52.620617,"twenty":13.438915,"median":26.87804,"eighty":41.030913,"marketCap":26669181236},{"date":"2022-11-18","current":51.362611,"twenty":13.477144,"median":26.991976,"eighty":41.419994,"marketCap":26031598351},{"date":"2022-11-25","current":51.494402,"twenty":13.508626,"median":27.128959,"eighty":41.588023,"marketCap":26098392749},{"date":"2022-12-02","current":52.53675,"twenty":13.524865,"median":27.163206,"eighty":41.70117,"marketCap":26626675710},{"date":"2022-12-09","current":50.020737,"twenty":13.531271,"median":27.175694,"eighty":42.099572,"marketCap":25351509941},{"date":"2022-12-16","current":48.175661,"twenty":13.536595,"median":27.242334,"eighty":42.522809,"marketCap":24416388376},{"date":"2022-12-23","current":47.253123,"twenty":13.555525,"median":27.46898,"eighty":42.883467,"marketCap":23948827594},{"date":"2022-12-30","current":47.348971,"twenty":13.573322,"median":27.509444,"eighty":43.081148,"marketCap":23997405338},{"date":"2023-01-06","current":45.635686,"twenty":13.58452,"median":27.609843,"eighty":43.15977,"marketCap":23129078171},{"date":"2023-01-13","current":47.169255,"twenty":13.602481,"median":27.828632,"eighty":43.302904,"marketCap":23906322069},{"date":"2023-01-20","current":45.92323,"twenty":13.638343,"median":27.953974,"eighty":43.369326,"marketCap":23274811402},{"date":"2023-01-27","current":46.606148,"twenty":13.663787,"median":28.075391,"eighty":43.492269,"marketCap":23620927825},{"date":"2023-02-03","current":46.678034,"twenty":13.677842,"median":28.635778,"eighty":43.575059,"marketCap":23657361133},{"date":"2023-02-10","current":45.647667,"twenty":13.700329,"median":28.791441,"eighty":44.018571,"marketCap":23135150389},{"date":"2023-02-17","current":536.452748,"twenty":13.744823,"median":28.985327,"eighty":45.527856,"marketCap":22977344089},{"date":"2023-02-24","current":515.754518,"twenty":13.745207,"median":29.047283,"eighty":45.638082,"marketCap":22090797514},{"date":"2023-03-03","current":505.263634,"twenty":13.756547,"median":29.121037,"eighty":45.865721,"marketCap":21641451990},{"date":"2023-03-10","current":469.254386,"twenty":13.824571,"median":29.181811,"eighty":46.294641,"marketCap":20099103841},{"date":"2023-03-17","current":491.086765,"twenty":13.863361,"median":29.214845,"eighty":46.433622,"marketCap":21034228309},{"date":"2023-03-24","current":502.286492,"twenty":13.889221,"median":29.284382,"eighty":46.639695,"marketCap":21513935017},{"date":"2023-03-31","current":510.792614,"twenty":13.89653,"median":29.384716,"eighty":46.953597,"marketCap":21878269226},{"date":"2023-04-06","current":514.195062,"twenty":13.908662,"median":29.389187,"eighty":46.991936,"marketCap":22024002909},{"date":"2023-04-14","current":517.881048,"twenty":13.930103,"median":29.629008,"eighty":47.183633,"marketCap":22181881066},{"date":"2023-04-21","current":511.926763,"twenty":14.003344,"median":29.811522,"eighty":47.38731,"marketCap":21926847120},{"date":"2023-04-28","current":501.012305,"twenty":14.059562,"median":29.901277,"eighty":48.453621,"marketCap":21459359029},{"date":"2023-05-05","current":494.632691,"twenty":14.081953,"median":30.06718,"eighty":50.15732,"marketCap":21186107429},{"date":"2023-05-12","current":63.132216,"twenty":14.097435,"median":30.121467,"eighty":50.607807,"marketCap":20949289375},{"date":"2023-05-19","current":61.532363,"twenty":14.125705,"median":30.273353,"eighty":51.046312,"marketCap":20418037790},{"date":"2023-05-26","current":58.989098,"twenty":14.148386,"median":30.350248,"eighty":51.427308,"marketCap":19574116514},{"date":"2023-06-02","current":60.690707,"twenty":14.160754,"median":30.36188,"eighty":51.544722,"marketCap":20138754490},{"date":"2023-06-09","current":63.179081,"twenty":14.184848,"median":30.416167,"eighty":52.19192,"marketCap":20964461638},{"date":"2023-06-16","current":58.915911,"twenty":14.243506,"median":30.482087,"eighty":52.539205,"marketCap":19549831009},{"date":"2023-06-23","current":56.738584,"twenty":14.315085,"median":30.602294,"eighty":52.629752,"marketCap":18827337255},{"date":"2023-06-29","current":54.158725,"twenty":14.348803,"median":30.610049,"eighty":52.716465,"marketCap":17971273226},{"date":"2023-07-07","current":55.787147,"twenty":14.368253,"median":30.7225,"eighty":53.147934,"marketCap":18511625698},{"date":"2023-07-14","current":56.189678,"twenty":14.385627,"median":30.817667,"eighty":53.439755,"marketCap":18645195972},{"date":"2023-07-21","current":57.031334,"twenty":14.406989,"median":30.912504,"eighty":53.523133,"marketCap":18924479272},{"date":"2023-07-28","current":56.720287,"twenty":14.411846,"median":30.997812,"eighty":53.911359,"marketCap":18821265879},{"date":"2023-08-04","current":55.970115,"twenty":14.415735,"median":31.028834,"eighty":54.260503,"marketCap":18572339459},{"date":"2023-08-11","current":72.162914,"twenty":14.43566,"median":31.102508,"eighty":54.461129,"marketCap":18397718410},{"date":"2023-08-18","current":69.094161,"twenty":14.479538,"median":31.168428,"eighty":54.648729,"marketCap":17615348965},{"date":"2023-08-25","current":69.778729,"twenty":14.509418,"median":31.203327,"eighty":54.763373,"marketCap":17789877534},{"date":"2023-09-01","current":70.392479,"twenty":14.580141,"median":31.269247,"eighty":54.978425,"marketCap":17946351423},{"date":"2023-09-08","current":68.126323,"twenty":14.602628,"median":31.455373,"eighty":55.107305,"marketCap":17368601679},{"date":"2023-09-15","current":67.890265,"twenty":14.667652,"median":31.928445,"eighty":55.289693,"marketCap":17308419414},{"date":"2023-09-22","current":61.988816,"twenty":14.847176,"median":32.246411,"eighty":55.641442,"marketCap":15803862789},{"date":"2023-09-29","current":63.216318,"twenty":14.859728,"median":32.339474,"eighty":55.973774,"marketCap":16116810567},{"date":"2023-10-06","current":62.767808,"twenty":15.016671,"median":32.482946,"eighty":56.080794,"marketCap":16002464263},{"date":"2023-10-13","current":63.971703,"twenty":15.066953,"median":32.556622,"eighty":56.189678,"marketCap":16309393815},{"date":"2023-10-20","current":66.355888,"twenty":15.150362,"median":32.773769,"eighty":56.544637,"marketCap":16917234691},{"date":"2023-10-27","current":64.32579,"twenty":15.218983,"median":32.928874,"eighty":56.599178,"marketCap":16399667212},{"date":"2023-11-03","current":64.868723,"twenty":16.726003,"median":36.907039,"eighty":56.712968,"marketCap":16538086422},{"date":"2023-11-10","current":88.80003,"twenty":21.996708,"median":37.21566,"eighty":56.826842,"marketCap":16375613449},{"date":"2023-11-17","current":85.949098,"twenty":22.092944,"median":37.494887,"eighty":56.889499,"marketCap":15849873215},{"date":"2023-11-24","current":87.765402,"twenty":22.177931,"median":37.592862,"eighty":57.067927,"marketCap":16184817745},{"date":"2023-12-01","current":65.305922,"twenty":22.190429,"median":37.666342,"eighty":57.217798,"marketCap":12043065075},{"date":"2023-12-08","current":69.407144,"twenty":22.271667,"median":37.730026,"eighty":57.452297,"marketCap":12799371342},{"date":"2023-12-15","current":69.069396,"twenty":22.390399,"median":37.75452,"eighty":57.77799,"marketCap":12737087296},{"date":"2023-12-22","current":66.053792,"twenty":22.540377,"median":37.955368,"eighty":58.915911,"marketCap":12180979747},{"date":"2023-12-29","current":67.453032,"twenty":22.562873,"median":37.997597,"eighty":59.09156,"marketCap":12439013650},{"date":"2024-01-05","current":67.067035,"twenty":22.579121,"median":38.02395,"eighty":59.439201,"marketCap":12367831884},{"date":"2024-01-12","current":69.021146,"twenty":22.595368,"median":38.190507,"eighty":60.273538,"marketCap":12728189575},{"date":"2024-01-19","current":67.646031,"twenty":22.640362,"median":38.303178,"eighty":60.799389,"marketCap":12474604533},{"date":"2024-01-26","current":70.227388,"twenty":22.677856,"median":38.50491,"eighty":61.532363,"marketCap":12950632595},{"date":"2024-02-02","current":69.19002,"twenty":22.884075,"median":38.587304,"eighty":61.916597,"marketCap":12759331598},{"date":"2024-02-09","current":69.23827,"twenty":22.890324,"median":38.625868,"eighty":62.198957,"marketCap":12768229319},{"date":"2024-02-16","current":11.82036,"twenty":22.884075,"median":38.696427,"eighty":62.821129,"marketCap":13414146195},{"date":"2024-02-23","current":12.210042,"twenty":22.58287,"median":38.613793,"eighty":62.778472,"marketCap":13856370795},{"date":"2024-03-01","current":11.942381,"twenty":22.255419,"median":38.523621,"eighty":62.312727,"marketCap":13552620565},{"date":"2024-03-08","current":11.824296,"twenty":20.664972,"median":38.430545,"eighty":62.163037,"marketCap":13418613110},{"date":"2024-03-15","current":11.749508,"twenty":15.016671,"median":38.210102,"eighty":62.021864,"marketCap":13333741722},{"date":"2024-03-22","current":11.977807,"twenty":14.597006,"median":38.097431,"eighty":61.966617,"marketCap":13592822801},{"date":"2024-03-28","current":11.98568,"twenty":14.455899,"median":37.997597,"eighty":61.934385,"marketCap":13601756631},{"date":"2024-04-05","current":11.30472,"twenty":14.395746,"median":37.829562,"eighty":61.889111,"marketCap":12828980310},{"date":"2024-04-12","current":11.434614,"twenty":14.190992,"median":37.744722,"eighty":61.843383,"marketCap":12976388510},{"date":"2024-04-19","current":10.978016,"twenty":14.097435,"median":37.720229,"eighty":61.737288,"marketCap":12458226353},{"date":"2024-04-26","current":11.170864,"twenty":13.930103,"median":37.622254,"eighty":61.590913,"marketCap":12677076753},{"date":"2024-05-03","current":11.429173,"twenty":13.857739,"median":37.494887,"eighty":61.301823,"marketCap":12970214422},{"date":"2024-05-10","current":15.790439,"twenty":13.745111,"median":37.220558,"eighty":61.104216,"marketCap":12613939409},{"date":"2024-05-17","current":15.739176,"twenty":13.753736,"median":37.112786,"eighty":60.998094,"marketCap":12573351116},{"date":"2024-05-24","current":15.157707,"twenty":13.808268,"median":34.822839,"eighty":60.858379,"marketCap":12108840655},{"date":"2024-05-31","current":14.898022,"twenty":13.852118,"median":32.773769,"eighty":60.755916,"marketCap":11901389381},{"date":"2024-06-07","current":15.331469,"twenty":13.879102,"median":32.556622,"eighty":60.617519,"marketCap":12247651204},{"date":"2024-06-14","current":15.393723,"twenty":13.894843,"median":32.486824,"eighty":60.463826,"marketCap":12297383268},{"date":"2024-06-21","current":15.071134,"twenty":13.897092,"median":32.455803,"eighty":60.288176,"marketCap":12039680751},{"date":"2024-06-28","current":15.093772,"twenty":13.904805,"median":32.339474,"eighty":60.258901,"marketCap":12057765138},{"date":"2024-07-05","current":14.669312,"twenty":13.920951,"median":32.246411,"eighty":60.178394,"marketCap":11718682879},{"date":"2024-07-12","current":15.127728,"twenty":13.960618,"median":31.928445,"eighty":60.006404,"marketCap":12084891719},{"date":"2024-07-15","current":15.150366,"twenty":13.981981,"median":31.796605,"eighty":59.980789,"marketCap":12102976106},{"date":"2024-08-02","current":16.123793,"twenty":14.003344,"median":31.734563,"eighty":59.955173,"marketCap":12880604754},{"date":"2024-08-09","current":17.406437,"twenty":14.059562,"median":31.277002,"eighty":59.651445,"marketCap":11718640189},{"date":"2024-08-16","current":18.245141,"twenty":14.081953,"median":31.218837,"eighty":59.351376,"marketCap":12283285949},{"date":"2024-08-23","current":18.458146,"twenty":14.097435,"median":31.168428,"eighty":59.252573,"marketCap":12426688047},{"date":"2024-08-30","current":19.390039,"twenty":14.125705,"median":31.141285,"eighty":59.09156,"marketCap":13054072226},{"date":"2024-09-06","current":19.350101,"twenty":14.146138,"median":31.063732,"eighty":58.974461,"marketCap":13027184332},{"date":"2024-09-13","current":18.338331,"twenty":14.160754,"median":31.005568,"eighty":58.937867,"marketCap":12346024367},{"date":"2024-09-20","current":18.631211,"twenty":14.184848,"median":30.990057,"eighty":58.879317,"marketCap":12543202252},{"date":"2024-09-27","current":18.764339,"twenty":14.243506,"median":30.904749,"eighty":58.641458,"marketCap":12632828563},{"date":"2024-10-04","current":18.471458,"twenty":14.326324,"median":30.775014,"eighty":58.287732,"marketCap":12435650679},{"date":"2024-10-11","current":18.298392,"twenty":14.368253,"median":30.610049,"eighty":58.012489,"marketCap":12319136474},{"date":"2024-10-18","current":18.67115,"twenty":14.390686,"median":30.54413,"eighty":57.699824,"marketCap":12570090145},{"date":"2024-10-25","current":18.158608,"twenty":14.408114,"median":30.465593,"eighty":57.566941,"marketCap":12225028847},{"date":"2024-10-31","current":18.098701,"twenty":14.411846,"median":30.382231,"eighty":57.528884,"marketCap":12184697007},{"date":"2024-11-08","current":10.289745,"twenty":14.406989,"median":30.354125,"eighty":57.466826,"marketCap":11782880049},{"date":"2024-11-15","current":9.925026,"twenty":14.223393,"median":30.330859,"eighty":57.444951,"marketCap":11365236488},{"date":"2024-11-22","current":10.243185,"twenty":14.10977,"median":30.171876,"eighty":57.378974,"marketCap":11729563850},{"date":"2024-11-29","current":10.344065,"twenty":14.04607,"median":30.088852,"eighty":57.232599,"marketCap":11845082282},{"date":"2024-12-06","current":10.239305,"twenty":13.894281,"median":29.997383,"eighty":57.230825,"marketCap":11725120833},{"date":"2024-12-13","current":9.781466,"twenty":13.745303,"median":29.892686,"eighty":57.217798,"marketCap":11200844873},{"date":"2024-12-20","current":9.420627,"twenty":13.663787,"median":29.795746,"eighty":57.141115,"marketCap":10787644329},{"date":"2024-12-27","current":9.855186,"twenty":13.579288,"median":29.601864,"eighty":57.126477,"marketCap":11285262189},{"date":"2025-01-03","current":10.006506,"twenty":13.531271,"median":29.389187,"eighty":57.100862,"marketCap":11458539837},{"date":"2025-01-10","current":10.165586,"twenty":13.458029,"median":29.384716,"eighty":57.078905,"marketCap":11640703518},{"date":"2025-01-17","current":12.008583,"twenty":13.264639,"median":29.284382,"eighty":57.05329,"marketCap":13751136407},{"date":"2025-01-24","current":11.880543,"twenty":13.173566,"median":29.224184,"eighty":57.011305,"marketCap":13604516859},{"date":"2025-01-31","current":12.256903,"twenty":13.053885,"median":29.19859,"eighty":56.923371,"marketCap":14035489470},{"date":"2025-02-07","current":12.183183,"twenty":12.930518,"median":29.127468,"eighty":56.889499,"marketCap":13951072155},{"date":"2025-02-14","current":16.37486,"twenty":12.913057,"median":29.097649,"eighty":56.873866,"marketCap":14065726416},{"date":"2025-02-21","current":16.813743,"twenty":12.927331,"median":28.991567,"eighty":56.853021,"marketCap":14442719083},{"date":"2025-02-28","current":16.833921,"twenty":12.943264,"median":28.872386,"eighty":56.839993,"marketCap":14460052079},{"date":"2025-03-07","current":16.788519,"twenty":12.984673,"median":28.666911,"eighty":56.830068,"marketCap":14421052838},{"date":"2025-03-14","current":16.485842,"twenty":13.031997,"median":28.143472,"eighty":56.813938,"marketCap":14161057895},{"date":"2025-03-21","current":16.899501,"twenty":13.049744,"median":27.981993,"eighty":56.738584,"marketCap":14516384317},{"date":"2025-03-28","current":15.966245,"twenty":13.070449,"median":27.828632,"eighty":56.720287,"marketCap":13714733243},{"date":"2025-04-04","current":16.03687,"twenty":13.112851,"median":27.609843,"eighty":56.720287,"marketCap":13775398729}],"updateTime":1743913983922}}}